🔥The 9th Round of Easy Loan, Earn $40 Reward is in progress❗️ ⏰ Promotion Period: January 15th - Feburary 15th, 2025 👉 Register now and check more details at gate.io/campaigns/358

Today is #WorldCancerDay. Umoja supports @UICC's efforts to champion accessible #CancerTherapies globally, acknowledging the imperative to #CloseTheCareGap. Find out more about how to amplify this collective impact here: worldcancerday.org/join-call-to-a…

Opening our doors to students at The CLIMB gave us a peek at the next generation of talented #LifeScience leaders. We're glad to partner with the CBSI Mentor Program and share our expertise, industry insights, and passion for #biotech innovation. #CLIMBHigher

Umoja will present at #SXSW! Our CEO, Andrew Scharenberg, MD, will join a dynamic panel with leading experts to discuss the revolutionary potential of viruses in medicine. Don't miss out, find more details here: brnw.ch/21wH0pD #MedicinesGoViral

Our CEO Andrew Scharenberg is participating in a virtual fireside chat at the Evercore ISI 2024 Emerging Biotech Conference on February 29 at 10:45 a.m. ET. Access the webcast here: brnw.ch/21wHdos

We’re excited to announce the appointment of Britton Russell as our Chief Financial Officer. His leadership will be key as we expand the reach and effectiveness of #CARTcell therapeutics across multiple indications. Learn more here: umoja-biopharma.com/news/umoja-bio…

Our COO, David Fontana, and SVP, General Counsel, Chris Moore, will lead a workshop on the current #CellTherapy investment space at CAR-TCR's #CARTCR Europe. Join us to discuss reinvigorating investment in this promising space after a challenging year: brnw.ch/21wHpca

In a few days our CEO Andrew Scharenberg hits Austin, TX for #SXSW! He is joining MicrobeTV & Steffanie Strathdee, PhD 🗡️ 🦠Superbug Slayer🗡️ for a panel on March 12th to discuss the potential of viruses as medicines & our #VivoVec platform. Find more details here: schedule.sxsw.com/2024/events/PP… #MedicinesGoViral

For #InternationalWomensDay, we're excited to highlight Sally Dyer, a people + operations leader at Umoja who drives us to #InspireInclusion across the work we do and the communities we serve. We're proud to celebrate the women leaders shaping our future every day. #IWD2024

Our CEO, Andrew Scharenberg, MD, has arrived at #SXSW for his presentation on how Umoja's using #LentiviralVectorsfor #CARTcelltherapies. Find additional information here: schedule.sxsw.com/2024/events/PP… #SXSW2024 #MedicinesGoViral

Our CEO, Andrew Scharenberg, will present a corporate overview at H.C. Wainwright & Co.’s 2nd Annual Cell Therapy Virtual Conference on March 26. Members of our leadership team will also be available for one-on-one meetings during the conference. Find more details here: umoja-biopharma.com/news/umoja-bio…

Our CEO, Andrew Scharenberg, MD, CAR T pioneer Carl June and Stephen Russell, MD, PhD will be in New York City for the Alliance for Cancer Gene Therapy Summit 2024 tomorrow to share insights on the progress and challenges of in vivo #CGT. Learn more here: bit.ly/3TzsZLS

Umoja will present at Cell & Gene Meeting on the Med! Our COO, David Fontana, will be participating in the Company Presentations on Wednesday, April 10. The presentation will be streamed for virtual attendees. More: meetingonthemed.com/agenda/ #CGMed24

For #NationalVolunteerWeek, we're highlighting the great work Umojians are doing to shine light on #STEM careers all over Seattle and in Colorado. Thank you, Alessandra, for your work connecting Umoja with young talent so we can show them new opportunities. #GlobalVolunteerMonth

Grateful to host Colorado School of Mines’ ambitious graduate students at The CLIMB earlier this month! We enjoyed sharing our #CGT vision for Umoja and The CLIMB with the next generation of #biotech leaders.

Umoja will present at the 27th ASGCT Annual Meeting! We are excited to attend alongside other industry leaders and present pharmacokinetics data regarding our #VivoVec platform. Read the abstract here: bit.ly/3JJlCgp #ASGCT2024

Our CEO, Andrew Scharenberg, MD, was recently featured on the Talking Biotech podcast! Listen to the episode to learn how Umoja is engineering #CARTcells #InVivo to create more effective #CellTherapies: share.transistor.fm/s/a2e93342

Ashley Yingst's abstract on Synthetic Receptor Enabled Differentiation received the ISCT Stem Cell Engineering Abstract Award! This recognition reflects our commitment to advancing "off-the-shelf" #Immunotherapies. More on this prestigious award: bit.ly/3y8QPak

Here at Umoja, our world-class team is united by our shared goal of unlocking the true potential of #CART cell therapies. We're recognizing #WorldBloodCancerDay by sharing our commitment to extending the benefits of #immunotherapy to every patient bearing the burden of #cancer.

In our latest blog post, CEO Andrew Scharenberg reflects on his experience as a #SXSW2024 panelist and details his goal of advancing practice-changing #CellTherapies. Read more about the benefits of reimagining viruses as medicine: umoja-biopharma.com/blog/taking-th… #MedicinesGoViral

We are honored to announce the publication of the first successful #InVivo #CARTcell data in @BloodJournal stemming from our pre-clinical investigations of our proprietary #VivoVec particles. Learn more about the validation of our #immunotherapy platform: umoja-biopharma.com/news/umoja-bio…